We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

5 hedge funds and large institutions have $185K invested in Aethlon Medical in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.8% less ownership

Funds ownership: 4.85% → 4.04% (-0.8%)

47% less capital inflows, than outflows

Capital inflows: $52K | Capital outflows: $98.3K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Cordasco Financial Network
Cordasco Financial Network
Florida
+$52K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$52K
2
Citadel Advisors
Citadel Advisors
Florida
-$17.3K
3
Virtu Financial
Virtu Financial
New York
-$11K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9K
5
HighTower Advisors
HighTower Advisors
Illinois
-$5K

AEMD Hedge Fund Activity: Q3 2019 in Review

5 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2019, worth a combined $185K — down 45% from $334K a quarter earlier.

Fund positioning in AEMD was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Cordasco Financial Network, opening a new position worth an estimated $52K. The largest seller was Vanguard Group, cutting an estimated $52K.

  • 5 institutional investors held Aethlon Medical (AEMD) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $185K of Aethlon Medical stock for Q3 2019, down 45% quarter-over-quarter.
  • 1 fund opened new Aethlon Medical positions in Q3 2019 and 1 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q3 2019 was Cordasco Financial Network, an estimated $52K added.
  • The largest Aethlon Medical seller in Q3 2019 was Vanguard Group, an estimated $52K sold.

Based on aggregated 13F filings for Q3 2019.